Table 1.
# | General Material | Nanofiber Material | Analyte Tested | LDL | Precision (RSD) | Sensing Mech. + | Ref. |
---|---|---|---|---|---|---|---|
1 | Carbon | TiO2/CNF | Idarubicin hydrochloride | 3 µM | 2.40% | AD | [35] |
2 | Organic polymer/metal oxide | PLC/ZnO-NPs/CuO-NFs | Adenine, guanine | 12.48 nM | 2.3% | EC | [36] |
Guanine | 1.25 nM | 1.2% | |||||
3 | Metal oxide | CeBiOx | Acetaminophen | 0.2 µM | 0.49% | EC | [37] |
4 | Organic polymer | 3D CuxO-ZnO NP/PPyNF/RGO | Ascorbic acid | 0.024 µM | 0.67% | AD, EC | [38] |
Dopamine | 0.012 µM | 0.81% | |||||
Paracetamol | 0.01 µM | 0.95% | |||||
Tryptophan | 0.016 µM | 1.14% | |||||
5 | Organic polymer/metal oxide | PANI NF/PEG | DNA sequence | 0.0038 pM | 5.80% | AD and ASR | [39] |
6 | Peptide | GQD/PNF/GO | Hydrogen Peroxide | 1.056 µM | N/R* | AD, EC | [40] |
7 | Carbon | NGQD/NCNF | Nitrite | 3 µM | 4.27% | EC | [41] |
8 | Organic polymer/metal oxide | CuO/PANI NF | H2O2 | 0.110 µM | N/R* | AD, EC | [42] |
Glucose | 0.45 µM | N/R | |||||
9 | Carbon/metal/organic polymer | PMB-Cu-NF/ACF | Creatinine | 0.2 ng/mL | 1–2% | EC, AD, and ASR | [43] |
10 | Metal oxide | SnO2 | Atrazine | 0.9 zM | 2.5% | AD and ASR | [44] |
11 | Peptide | PNF | Breast cancer stem-like cells | 6 cells/mL | Within 10% | ASR | [45] |
Key: N/R, not reported; N/R*, accuracy was reported but not precision. Nanofiber material abbreviations defined in Abbreviations: Back Matter. + Sensing mechanism: EC, electrocatalytic; AD, adsorption; ASR, analyte-specific recognition.